Vancouver, British Columbia--(Newsfile Corp. - February 6, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is excited to announce that it has completed initial sales of VIVI Cap, VIVI Cap Smart, VIVI Epi, and VIVI Med to pharmacies operated by Maccabi Healthcare Services ("Maccabi") and has launched a national in-pharmacy marketing campaign to put its products ...

Core Viewpoint - TempraMed Technologies Ltd. has launched VIVI Cap Smart, an advanced version of its original VIVI Cap product, integrating digital health functionality with temperature-protection technology for better management of temperature-sensitive medications [1][4]. Product Overview - VIVI Cap Smart enhances the original VIVI Cap by providing continuous protection for insulin and GLP-1 pens against temperature fluctuations without user intervention [2]. - The device utilizes proprietary, space-grade technology to safeguard insulin and other critical medications, reducing waste and improving patient outcomes [2]. Digital Functionality - The new product includes an integrated digital layer that allows users to automatically track injection timing and maintain an accurate log of insulin usage via a connected mobile application [3]. - This data can be shared with healthcare providers to support integrated treatment plans [3]. Strategic Direction - The introduction of VIVI Cap Smart marks a strategic move towards a comprehensive patient care platform that combines physical devices with digital tools, aimed at simplifying daily management for chronic illness patients [4][9]. - The product is designed to enhance adherence, tracking, and communication with caregivers and healthcare professionals [4]. Business Model and Revenue - VIVI Cap Smart introduces a subscription-based model through the connected mobile application, creating opportunities for recurring revenue from both existing and new customers [9]. - The digital offering is expected to unlock significant data opportunities for tracking compliance, efficacy, and side effects in collaboration with pharmaceutical and healthcare providers [9]. Company Background - TempraMed Technologies Ltd. is a leader in temperature-controlled medication storage solutions, developing patented, FDA-registered devices that operate without batteries or external power [7]. - The company aims to protect the effectiveness of life-saving medications and is expanding its product portfolio to better serve patients globally [7].